Pri­vate sec­tor health­care provider, Med­corp, and leg­endary bats­man Bri­an Lara yes­ter­day said the name of The Bri­an Lara Can­cer Treat­ment Cen­tre has not changed.

The state­ment came in a news re­lease yes­ter­day, one day af­ter the Sun­day Guardian pub­lished a pho­to­graph, tak­en on Sat­ur­day, which showed that Bri­an Lara’s name had been re­moved from the can­cer treat­ment cen­tre.

The Sun­day Guardian quot­ed Lara as say­ing his le­gal team had sent a let­ter to the Med­corp board of di­rec­tors. Asked if he wished to have his name re­moved from the can­cer treat­ment cen­tre, Lara told the Sun­day Guardian, “No, that is not the case. It’s a sit­u­a­tion where we sent them a let­ter, and they have to re­spond. Un­til then, I pre­fer to have no com­ment. We wait for their re­sponse.”

Yes­ter­day, in the joint news re­lease, the com­pa­ny and the crick­et leg­end said, “Med­corp Ltd and Mr Bri­an Lara con­firm that the name of The Bri­an Lara Can­cer Treat­ment Cen­tre has not changed. The re­la­tion­ship be­tween Mr Lara and Med­corp Ltd has been pos­i­tive and pro­duc­tive over al­most two decades.”

The news re­lease said while Lara con­tin­ues to gra­cious­ly al­low his name to be as­so­ci­at­ed with The Bri­an Lara Can­cer Treat­ment Cen­tre,” he wish­es to make it clear that he has not en­dorsed, and is not af­fil­i­at­ed with the Med­corp Ini­tial Pub­lic Of­fer­ing (IPO).

“The IPO is a sep­a­rate cor­po­rate ini­tia­tive by Med­corp in which Mr Lara plays no role and has giv­en no ap­proval or sup­port.”

On May 27, Med­corp opened the IPO in which it pro­pos­es to is­sue 350,000 new shares at the price of $48 a share, there­by gen­er­at­ing gross pro­ceeds of $16.8 mil­lion.

Apart from The Bri­an Lara Can­cer Treat­ment Cen­tre, Med­corp op­er­ates St Clair Med­ical Cen­tre, Good­health Med­ical Cen­tre and the Doc­tors Ra­di­ol­o­gy Cen­tre. Med­corp is al­so a 50 per cent share­hold­er in a joint ven­ture, Caribbean Heart Care, Med­corp Ltd, which op­er­ates Caribbean Heart Care Med­corp, a full-ser­vice car­dio­vas­cu­lar care cen­tre.

In its fi­nan­cial year end­ed De­cem­ber 31, 2024, Med­corp rev­enue of $122.23 mil­lion and prof­it af­ter tax of $41.3o mil­lion.

The com­pa­ny is cur­rent­ly owned by a group of 70 share­hold­ers. Of Med­corp’s 70 share­hold­ers, there are four share­hold­ers who are deemed to be “con­nect­ed per­sons” for the pur­pose of the Se­cu­ri­ties Act.

Those four share­hold­ers joint­ly con­trol 65.51 per cent of the com­pa­ny’s is­sued or­di­nary shares.